Thus, metabolic changes may be key players in many disorders, including depression [91, 92]
Pivotal Phase 2 Trial Results The pivotal Phase 2 trial, published by Jastreboff and colleagues in the New England Journal of Medicine in August 2023, enrolled 338 adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity but without diabetes
Eligibility can change based on how the prescription is categorized and how your plan administrator reviews the claim
Above 50, use a 1.0 ml syringe
PlexusDx provides personalized GLP-1 therapy across multiple formats to match your preferences and treatment goals
GLP-1 receptor activation slows gastric emptying, which can lead to constipation in certain individuals